Kidney, limb and ophthalmic complications, and death in patients with nonvalvular atrial fibrillation and type 2 diabetes prescribed rivaroxaban or warfarin: an electronic health record analysis

CONCLUSIONS: Rivaroxaban was associated with reduced incidence rates of kidney and limb complications, and death in NVAF patients with type 2 diabetes compared to warfarin.CLINICALTRIALS.GOV IDENTIFIER: NCT04509193.PMID:34166150 | DOI:10.1080/03007995.2021.1947217

Source: Current Medical Research and Opinion - June 24, 2021 Category: Research Authors: Olivia S Costa Bridget O'Donnell Burcu Vardar Khaled Abdelgawwad Christopher W Brescia Nitesh Sood Craig I Coleman Source Type: research